Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Ra Medical Systems Q3 EPS $(4.36)

Ra Medical Systems Q3 EPS $(4.36)

Ra Medical Systems (AMEX:RMED) reported quarterly losses of $(4.36) per share.

byMichael Horton

November 14, 2022

1 minute read

Ra Medical Systems (AMEX:RMED) reported quarterly losses of $(4.36) per share.

Citigroup Maintains Neutral on Teladoc Health, Lowers Price Target to $33

By Benzinga Newsdesk

December 13, 10:34 AM

Citigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $36 to $33.

TDOC

Neutral But Noteworthy: Analyst Discusses Chevron’s Improving Well Productivity And Future Prospects

By Shivani Kumaresan

Today, 2:43 PM

Mizuho Securities USA analyst Nitin Kumar reiterated a

CVX

Earnings

A Preview Of Robinhood Markets’s Earnings

By Benzinga Insights

February 12, 10:00 AM

Robinhood Markets (NASDAQ:HOOD) is set to give its latest quarterly earnings report on Tuesday, 2024-02-13. Here’s what investors…

HOOD

M&A
News

Renasant Bank Acquires Republic Business Credit; Terms Not Disclosed

By Charles Gross

January 3, 7:04 PM

Renasant Corporation (NASDAQ: RNST) (the "Company") announced today that effective December 30, 2022, its wholly-owned subsidiary, Renasant Bank, has acquired Republic Business Credit (formally known as Continental Republic Capital, LLC) ("RBC") in an all cash transaction.

RNST

Ra Medical Systems Q3 EPS $(4.36)

Related Posts

Citigroup Maintains Neutral on Teladoc Health, Lowers Price Target to $33

Neutral But Noteworthy: Analyst Discusses Chevron’s Improving Well Productivity And Future Prospects

A Preview Of Robinhood Markets’s Earnings

Renasant Bank Acquires Republic Business Credit; Terms Not Disclosed